Open Access

Poster Session 6 - Chronic heart failure – pathophysiology and mechanisms

Event: ESC Congress 2018
Topic: European Society of Cardiology, Other
Session type: Poster Session
Date: 28 August 2018

Session

15 presentations in this session

Appropriate hemoglobin levels in HFpEF patients: results of Japanese heart failure syndrome with preserved ejection fraction (JASPER) registry

Speaker: Doctor K. Okuno (Philadelphia, US)
Thumbnail

Impact of left ventricular pressure overload on relaxation and stiffness in patients with preserved ejection fraction: noninvasive study using speckle tracking echocardiography

Speaker: Doctor S. Minatoguchi (Gifu, JP)
Thumbnail

Cyclic guanosine monophosphate enhancing therapeutic strategy for heart failure with preserved ejection fraction (cGETS study): effects on cardiac dysfunction and remodeling.

Speaker: Doctor E. Dal Canto (Utrecht, NL)
Thumbnail

Angiotensin converting enzyme 2 activity predicts outcome in heart failure with preserved ejection fraction

Speaker: Ms C. Binder (Vienna, AT)
Thumbnail

Renin activity is an independent predictor of outcome in patients with heart failure and preserved ejection fraction independent of RAAS blocker therapy

Speaker: Ms C. Binder (Vienna, AT)
Thumbnail

Extracellular volume fraction measured by cardiac magnetic resonance imaging can help to evaluate left ventricular stiffness noninvasively by representing histological collagen volume fraction

Speaker: Doctor T. Omori (Tsu , Mie, JP)
Thumbnail

Pathological insights to heart failure with preserved ejection fraction - A comparison of patients with and without diabetes.

Speaker: Doctor G. Gulsin (Leicester, GB)
Thumbnail

Influence of left atrial strain and stiffness on haemodynamics in heart failure with preserved ejection fraction

Speaker: Doctor F. Telles (Melbourne, AU)
Thumbnail

Heart failure with preserved ejection fraction (HFpEF) infrequently evolves towards a HFpEF-declined phenotype

Speaker: Doctor J. Lupon (Badalona, ES)
Thumbnail

Gender differences in the response to spironolactone in chronic systolic heart failure patients: a propensity matched analysis

Speaker: Mrs M. Khateeb (Riyadh, SA)
Thumbnail

15 speakers from this session

Doctor Keisuke Okuno

Temple University School of Medicine, Philadelphia (United States of America)
0 follower

Doctor Shingo Minatoguchi

Gifu University Graduate School of Medicine, Gifu (Japan)
0 follower

Doctor Elisa Dal Canto

University Medical Center Utrecht, Utrecht (Netherlands (The))
0 follower

Ms Christina Binder

Medical University of Vienna AKH, Vienna (Austria)
2 presentations
0 follower

Ms Christina Binder

Medical University of Vienna AKH, Vienna (Austria)
2 presentations
0 follower

Doctor Taku Omori

Mie University Graduate School of Medicine, Tsu , Mie (Japan)
0 follower

Doctor Gaurav Singh Gulsin

NIHR Leicester Biomedical Research Centre, Leicester (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Fernando Telles

Baker Heart and Diabetes Institute, Melbourne (Australia)
0 follower

Doctor Josep Lupon

Germans Trias i Pujol Hospital, Badalona (Spain)
0 follower

Mrs May Khateeb

King Abdulaziz Medical City, Riyadh (Saudi Arabia)
0 follower

Doctor Alberto Aimo

Sant'Anna School of Advanced Studies, Pisa (Italy)
4 presentations
0 follower

Doctor Jurgen Duchenne

KU Leuven, Leuven (Belgium)
1 follower

Doctor John Aalen

Oslo University Hospital, Oslo (Norway)
0 follower

Doctor Simone Burocchi

Belcolle Hospital, Viterbo (Italy)
0 follower

Doctor Michele D'Alto

AORN Ospedali dei Colli - Monaldi Hospital, Naples (Italy)
3 presentations
0 follower

This platform is supported by

logo Novo Nordisk